MS-DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
MS-DRG 848 is chemotherapy without acute leukemia as secondary diagnosis without cc/mcc, in MDC 17 (a medical DRG), at the without-CC/MCC level. Its FY2027 relative weight is 0.7756, so a case here pays less than the average Medicare inpatient stay (weight 1.0), with a geometric mean length of stay of 2.60 days. 3 ICD-10-CM principal diagnoses group into MS-DRGs 846–848 under the CMS definitions manual; the most-searched are listed below.
FY2027 payment factors
- Relative weight
- 0.7756
- Geometric mean LOS
- 2.60
- Arithmetic mean LOS
- 3.00
- Post-acute transfer
- No
Principal diagnoses that group to MS-DRGs 846–848
From the CMS MS-DRG definitions manual’s principal-diagnosis index: 3 ICD-10-CM codes route here, and the CC/MCC status of the secondary diagnoses decides which of 846–848 the case lands in. The 3 most-searched:
The severity splits
Same base DRG, split by whether a secondary diagnosis is a CC or MCC. The last column is the weight change from MS-DRG 848.
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC | 2.5302 | +1.7546 |
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC | 1.3490 | +0.5734 |
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC | 0.7756 |
All FY2027 MS-DRGs · MDC 17